The Current Ratio as of September 2024 (TTM) for Neurocrine Biosciences, Inc. (NBIX) is 4.19

According to Neurocrine Biosciences, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 4.19. This represents a change of 45.07% compared to the average of 2.89 of the last 4 quarters.

Neurocrine Biosciences, Inc. (NBIX) Historical Current Ratio (quarterly & annually)

How has NBIX Current Ratio performed in the past?

The mean historical Current Ratio of Neurocrine Biosciences, Inc. over the last ten years is 7.24. The current 4.19 Current Ratio has changed 5.69% with respect to the historical average. Over the past ten years (40 quarters), NBIX's Current Ratio was at its highest in in the March 2015 quarter at 26.66. The Current Ratio was at its lowest in in the December 2019 quarter at 1.47.

Neurocrine Biosciences, Inc. (NBIX) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Neurocrine Biosciences, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Neurocrine Biosciences, Inc. (NBIX) Average Current Ratio

How has NBIX Current Ratio performed in the past?

The current Current Ratio of Neurocrine Biosciences, Inc. (NBIX) is greater than its 3-year, greater than its 5-year, and less than than its 10-year historical averages

Neurocrine Biosciences, Inc. (NBIX) Current Ratio vs. Peers

How is NBIX’s Current Ratio compared to its peers?

Neurocrine Biosciences, Inc.’s Current Ratio is greater than Amphastar Pharmaceuticals, Inc. (3.52), greater than Collegium Pharmaceutical, Inc. (1.11), greater than Ironwood Pharmaceuticals, Inc. (3.92), greater than ANI Pharmaceuticals, Inc. (3.97), less than Deciphera Pharmaceuticals, Inc. (4.19), greater than Alkermes plc (2.99), greater than Avadel Pharmaceuticals plc (2.82), less than Intra-Cellular Therapies, Inc. (7.81), less than Dynavax Technologies Corporation (14.18), less than Pacira BioSciences, Inc. (6.82), greater than Eagle Pharmaceuticals, Inc. (2.16), greater than Prestige Consumer Healthcare Inc. (3.23), greater than Evotec SE (1.83), greater than Supernus Pharmaceuticals, Inc. (1.91),

Build a custom stock screener for Neurocrine Biosciences, Inc. (NBIX) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Neurocrine Biosciences, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Neurocrine Biosciences, Inc. (NBIX) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Neurocrine Biosciences, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.